ANGPTL3 Polyclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bs-5918R |
| Product Name | ANGPTL3 Polyclonal Antibody |
| Applications |
WB
ELISA
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human ANG5/ANGPTL3 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 27329 |
| Swiss Prot | Q9Y5C1 |
| Subcellular location | Secreted |
| Synonyms | ANL3; ANG-5; FHBL2; ANGPT5; Angiopoietin-related protein 3; Angiopoietin-5; Angiopoietin-like protein 3; ANGPTL3; UNQ153/PRO179 |
| Background | Angiopoietin-like protein 3 (Angptl3) functions as a potent lipoprotein lipase inhibitor and is an important component of plasma triglyceride homeostasis. Angptl3 also plays a role in adipose formation and angiogenesis through its interaction with integrin ?v)beta(3). It is secreted by the liver and is functionally defined by the C-terminal fibrinogen (FBN)-like domain and an N-terminal coiled-coil domain. Angptl3 regulates circulating triglyceride levels during different nutritional states thereby mediating the feeding/fasting cycle. A deficiency of Angptl3 results in abnormally low lipid levels, and a repression of the protein may be protective against atherosclerosis. Angptl3 may also play an important role in hyperlipidemia in diabetes. |
| Application Dilution | |
| WB | 1:300-5000 |
| ELISA | 1:500-1000 |